A study published today in the American Medical Association’s journal JAMA Psychiatry reports that patients whose antipsychotic treatment was reduced or discontinued (DR) experienced a recovery rate twice that of patients maintained on antipsychotics (MT). “To our knowledge, this study is the first to identify major advantages of a DR strategy over MT in patients with remission of FEP,” the authors write. “Benefits that were not evident in short-term evaluations, such as functional gains, only appeared during long-term monitoring.”